Tango Therapeutics
TNGX
TNGX
115 hedge funds and large institutions have $652M invested in Tango Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18.15% more ownership
Funds ownership: 99.24% → 117.39% (+18%)
6% less funds holding
Funds holding: 122 → 115 (-7)
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
Holders
115
Holding in Top 10
7
Calls
$1.32M
Puts
$97K
Top Buyers
| 1 | +$14.6M | |
| 2 | +$13.7M | |
| 3 | +$11.2M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$4.95M |
| 5 |
CC
Commodore Capital
New York
|
+$3.71M |
Top Sellers
| 1 | -$3.23M | |
| 2 | -$2.2M | |
| 3 | -$1.51M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.28M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$1.04M |